rs61750120
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM5PP3_ModeratePP5_Very_Strong
The NM_000350.3(ABCA4):c.3322C>T(p.Arg1108Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000194 in 1,614,208 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1108H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000350.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCA4 | NM_000350.3 | c.3322C>T | p.Arg1108Cys | missense_variant | 22/50 | ENST00000370225.4 | NP_000341.2 | |
ABCA4 | XM_047416704.1 | c.3100C>T | p.Arg1034Cys | missense_variant | 21/49 | XP_047272660.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA4 | ENST00000370225.4 | c.3322C>T | p.Arg1108Cys | missense_variant | 22/50 | 1 | NM_000350.3 | ENSP00000359245 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251330Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135842
GnomAD4 exome AF: 0.000195 AC: 285AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.000194 AC XY: 141AN XY: 727236
GnomAD4 genome AF: 0.000184 AC: 28AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74498
ClinVar
Submissions by phenotype
not provided Pathogenic:7Other:1
not provided, no classification provided | literature only | Retina International | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 29, 2015 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Sep 15, 2021 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1108 of the ABCA4 protein (p.Arg1108Cys). This variant is present in population databases (rs61750120, gnomAD 0.02%). This missense change has been observed in individual(s) with Stargardt disease and retinitis pigmentosa (PMID: 10958763, 11379881, 16703556, 26103963, 30337596). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 92867). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ABCA4 function (PMID: 26092729). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 26, 2023 | Published functional studies demonstrate a damaging, temperature-sensitive processing effect on the ABCA4 protein (Sabirzhanova et al., 2015); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 11379881, 19074458, 24713488, 11702214, 26354092, 23757202, 11527935, 11726554, 11328725, 29555955, 28118664, 28559085, 32531858, 25283059, 16917483, 23918662, 9781034, 10958763, 26103963, 16703556, 30337596, 30653986, 31456290, 32845050, 32467599, 31589614, 32619608, 32037395, 33732702, 35119454, 35656873, 34216551, 9973280, 29925512, 26092729) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | ABCA4: PM3:Very Strong, PM2, PM5, PP3, PS3:Supporting - |
Severe early-childhood-onset retinal dystrophy Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory of Medical Genetics, National & Kapodistrian University of Athens | Oct 05, 2021 | PM1, PM2, PM5, PP3, PP5 - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 17, 2020 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Pathogenic, no assertion criteria provided | research | Ophthalmo-Genetics Lab, Instituto de Oftalmologia Conde de Valenciana | - | - - |
Age related macular degeneration 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jan 01, 2016 | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PM2,PM3,PM5,PP3,PP5. - |
ABCA4-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 19, 2024 | The ABCA4 c.3322C>T variant is predicted to result in the amino acid substitution p.Arg1108Cys. This variant has been reported many times in the compound heterozygous state in individuals with Stargardt disease (see for examples Rozet et al. 1998. PubMed ID: 9781034; Bertelsen et al. 2014. PubMed ID: 24713488; Duncker et al. 2015. PubMed ID: 25283059; Zhu et al. 2021. PubMed ID: 33732702). This variant is reported in 0.020% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant has been classified as pathogenic by the majority of ClinVar submitters (https://www.ncbi.nlm.nih.gov/clinvar/variation/92867/). Given the evidence, we interpret this variant as pathogenic. - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Aug 16, 2019 | - - |
Severe early-childhood-onset retinal dystrophy;C1858806:Cone-rod dystrophy 3;C1866422:Retinitis pigmentosa 19;C3495438:Age related macular degeneration 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 07, 2021 | - - |
Stargardt disease Pathogenic:1
Pathogenic, no assertion criteria provided | research | Sharon lab, Hadassah-Hebrew University Medical Center | Jun 23, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at